Vanguard Global Advisers »

Urogen Pharma shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $152k 8.5k 17.98

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Urogen Pharma

Rtw Investments
BlackRock
Toronto-Dominion Bank
Morgan Stanley
Kynam Capital Management
Leucadia National Corporation
Silverarc Capital Management
Paradigm Biocapital Advisors
SG Americas Securities
Acorn Capital Advisors
Opaleye Management
American Century Companies
Menora Mivtachim Holdings
Healthcare Of Ontario Pension Plan Trust Fund
D. E. Shaw & Co

View all funds holding Urogen Pharma